NOVARTIS INDIA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Novartis India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.21₹ -11.1
As on Sep 15, 2025, 4:01 PM IST
Novartis India Price Performance
Today's LowToday's High
₹905.00₹926.05
₹907.00
52 Weeks' Low52 Weeks' High
₹744.95₹1,248.00
₹907.00
Open Price
₹923.85
Prev. Close
₹918.10
Volume
5,536
Over the last 5 years, the share price of Novartis India has gained 6.66% CAGR. Over the past year, the corresponding return has been -15.49%.
Novartis India’s current P/E of 21.79x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Novartis India Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Novartis India | -2.50 | -2.78 | -9.43 | 21.56 | -13.86 | 7.84 | 6.66 |
| Sun Pharmaceutical Industries | 0.46 | -1.83 | -4.93 | -6.07 | -13.98 | 21.68 | 26.44 |
| Divi's Laboratories | 0.68 | -2.03 | -9.69 | 6.55 | 10.26 | 18.00 | 13.79 |
| Cipla | -0.18 | -0.98 | 1.45 | 3.75 | -6.67 | 13.52 | 16.50 |
| Torrent Pharmaceuticals | -3.05 | -3.34 | 7.71 | 15.39 | 2.27 | 32.67 | 20.35 |
| Dr. Reddy's Laboratories | 0.65 | 3.01 | -3.33 | 13.16 | -2.09 | 15.26 | 8.32 |
| Mankind Pharma | -0.41 | 4.42 | 8.91 | 18.73 | 4.99 | 21.89 | 12.61 |
| Zydus Lifesciences | 0 | 5.08 | 6.44 | 16.05 | -7.08 | 40.26 | 22.98 |
| Lupin | 4.49 | 3.93 | 1.81 | 2.80 | -9.12 | 44.83 | 16.16 |
| Abbott India | 1.08 | -5.07 | -2.16 | 2.66 | 6.29 | 19.99 | 13.39 |
| Alkem Laboratories | 3.00 | 2.66 | 12.83 | 14.01 | -13.62 | 19.58 | 13.54 |
| Aurobindo Pharma | 5.23 | 0.79 | -3.96 | -1.28 | -29.67 | 25.72 | 6.67 |
| Glenmark Pharmaceuticals | -0.85 | 6.28 | 24.71 | 46.64 | 20.47 | 74.71 | 34.18 |
| Laurus Labs | -0.70 | 3.54 | 31.78 | 54.09 | 77.57 | 17.47 | 27.44 |
| Biocon | -1.70 | -1.58 | 0.32 | 7.35 | -8.27 | 5.74 | -3.58 |
| Anthem Biosciences | 1.94 | 4.25 | 14.29 | 14.29 | 14.29 | 4.55 | 2.71 |
| GlaxoSmithKline Pharmaceuticals | -2.35 | -1.35 | -18.25 | 2.21 | -2.76 | 24.76 | 9.75 |
| Cohance Lifesciences | -3.42 | 9.49 | -0.98 | -13.33 | -15.99 | 26.86 | 22.11 |
| Ipca Laboratories | -0.43 | -5.15 | -3.58 | -0.16 | -9.98 | 13.54 | 4.09 |
| Gland Pharma | 4.52 | 1.75 | 13.40 | 29.15 | 7.54 | -6.26 | 1.96 |
Over the last one year, Novartis India has declined 13.86% compared to peers like Sun Pharmaceutical Industries (-13.98%), Divi's Laboratories (10.26%), Cipla (-6.67%). From a 5 year perspective, Novartis India has underperformed peers relative to Sun Pharmaceutical Industries (26.44%) and Divi's Laboratories (13.79%).
Novartis India Financials
Novartis India Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 925.09 | 921.53 |
| 10 | 925.85 | 924.14 |
| 20 | 929.32 | 931.94 |
| 50 | 979.69 | 952.61 |
| 100 | 958.58 | 950.99 |
| 200 | 919.27 | 947.94 |
Novartis India Share Holding Pattern
In the latest quarter, Novartis India remained same as its previous close in promoter holding, while DII stake unchanged at 0.53%, FII holding unchanged at 0.19%, and public shareholding moved down to 28.60% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Novartis India Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 160 | 0.05 | 0.01 |
Novartis India Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 02, 2025, 12:52 AM IST | Novartis - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Jul 31, 2025, 10:13 PM IST | Novartis - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Jul 29, 2025, 11:56 PM IST | Novartis - Announcement under Regulation 30 (LODR)-Change in Management |
| Jul 29, 2025, 10:41 PM IST | Novartis - Unaudited Financial Results For The Quarter Ended As On June 30, 2025. |
| Jul 29, 2025, 10:07 PM IST | Novartis - Board Meeting Outcome for Intimation About The Outcome Of The Board Meeting Held On July 29, 2025, Inter Alia For |
About Novartis India
Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 356.27 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressInspire - BKC, 7th Floor, Mumbai Maharashtra 400051
- Contact
Management
- Mr. Christopher SnookChairperson
- Mrs. Shilpa JoshiWholeTime Director & CFO
- Mr. Falin MajmudarWhole Time Director
- Mr. Sandra MartyresIndependent Director
- Mr. Sanker ParameswaranIndependent Director
- Mr. Gira SardesaiIndependent Director
FAQs on Novartis India Share Price
What is the share price of Novartis India?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Novartis India is ₹907.00 as on Sep 15, 2025.
What kind of stock is Novartis India?
The Novartis India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Novartis India?
The market cap of Novartis India is ₹2,239.46 Cr as on Sep 15, 2025.
What are today's High and Low prices of Novartis India?
Today’s highest and lowest price of Novartis India are ₹926.05 and ₹905.00.
What are the 52 Week High and 52 Week Low of Novartis India?
The 52-week high/low is the highest and lowest price at which Novartis India stock has traded in the past 52-week or nearly a year. The 52-week high of Novartis India is ₹1,248.00 and 52-week low of Novartis India is ₹744.95 as on Sep 15, 2025.
How has the Novartis India performed historically in terms of returns?
The Novartis India has shown returns of -1.21% over the past day, -4.6% for the past month, -10.0% over 3 months, -15.49% over 1 year, 7.84% across 3 years, and 6.66% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Novartis India?
P/E ratio of and PB ratio of Novartis India are 21.79 and 3.07 on Sep 15, 2025. While the company gives a dividend yield of 2.76 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data